×
Investors Relations. IR Home · Why Invest · Events ... Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P ... Ironwood Pharmaceuticals Q4 and Full Year 2023 Investor ...
Investors · IR Home · Events & Presentations · Corporate Governance · Governance Documents · Executive Management · Board of Directors · Financial Information.
5 days ago · Investors Relations. IR Home · Why Invest ... Quarterly Results. NASDAQ: IRWD7.92+0.32 (4.21%) ... Ironwood Pharmaceuticals 4Q 2023 Investor Update ...
State law regulates IRWD as to the types of fixed-income securities in which it can invest cash assets. In addition, the Board of Directors annually adopts an ...
People also ask
Class A Common Stock (IRWD) including earnings per share, earnings forecasts at Nasdaq ... Investor Relations Intelligence. Featured ... IRWD IRWD EARNINGS DATE ...
Vice President of Strategic Finance & Investor Relations, N/A, N/A, N/A. Ms. Beth Calitri, Head of Corporate Communications & Media Relations, N/A, N/A, N/A. Mr ...
Feb 15, 2024 · (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript February 15, 2024 8:30 AM ET. Company Participants. Matt Roache - Director of Investor Relations
Access Ironwood Pharmaceuticals Inc (IRWD) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using ...
IRWD | Complete Ironwood Pharmaceuticals Inc. Cl A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.